NVO

Novo Nordisk
NYSE

Real-time Quotes | Nasdaq Last Sale

60.30
+0.46
+0.77%
Opening 11:37 04/06 EDT
OPEN
59.89
PREV CLOSE
59.84
HIGH
60.53
LOW
59.58
VOLUME
687.97K
TURNOVER
--
52 WEEK HIGH
64.82
52 WEEK LOW
46.47
MARKET CAP
141.83B
P/E (TTM)
24.54
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NVO stock price target is 69.45 with a high estimate of 69.45 and a low estimate of 69.45.

EPS

NVO News

More
  • Highlights From Fundsmith Equity Fund s 2020 Investor Letter
  • Insider Monkey · 13h ago
  • Coronavirus (COVID-19) resources available from Novo Nordisk in the US
  • PR Newswire · 3d ago
  • FDA OKs new hemophilia treatment
  • Seeking Alpha - Article · 4d ago
  • NVS vs. NVO: Which Stock Should Value Investors Buy Now?
  • Zacks · 4d ago

Industry

Pharmaceuticals
+2.70%
Pharmaceuticals & Medical Research
+2.92%

Hot Stocks

Symbol
Price
%Change

About NVO

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
More

Webull offers kinds of Novo Nordisk A/S (ADR) stock information, including NYSE:NVO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NVO stock news, and many more online research tools to help you make informed decisions.